Advertisement
UK markets open in 4 hours 31 minutes
  • NIKKEI 225

    37,776.59
    -683.49 (-1.78%)
     
  • HANG SENG

    17,283.42
    +82.15 (+0.48%)
     
  • CRUDE OIL

    82.72
    -0.09 (-0.11%)
     
  • GOLD FUTURES

    2,331.50
    -6.90 (-0.30%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,571.58
    -1,882.56 (-3.52%)
     
  • CMC Crypto 200

    1,387.26
    -36.84 (-2.59%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

How Pfizer Performed across Geographies during 4Q17

How Pfizer Performed across Geographies during 4Q17

As discussed earlier, Pfizer’s (PFE) revenue rose ~1% to $13.7 billion during 4Q17 driven by increased sales of its Innovative Health products. It reflects revenues for both Pfizer’s Innovative Health and Essential Health segments in 4Q17. Pfizer reported a fall of ~4% in its US sales in 4Q17, while its sales outside US markets reported a 5% revenue rise in the quarter.